Pembrolizumab (urothelial carcinoma): Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 17 March 2023 Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 516KB) Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 154KB)